Two-electrode voltage clamp in Xenopus oocytes

• Use defolliculated Xenopus laevis oocytes as the expression host, inject capped cRNA or other nucleic-acid constructs encoding the target membrane protein, and incubate injected oocytes in oocyte culture solution before recording.

• Use a recording bath solution appropriate to the target current;
• ND96-type saline was used in a published TEVC protocol for SLAC1 recordings, and solution composition should be matched to the channel, transporter, ligand, or ion being tested rather than generalized across targets.

• Use 3 M KCl-filled glass microelectrodes for conventional TEVC, or agarose-cushion KCl electrodes when stable low-resistance cytosolic access and reduced KCl leakage are required.

• Dyes or fluorophores should only be added when the experiment is explicitly voltage-clamp fluorometry rather than TEVC alone.

• Use a two-electrode voltage-clamp amplifier, voltage-sensing and current-injecting microelectrodes, micromanipulators, an oocyte recording chamber, perfusion or solution-exchange hardware, a data-acquisition interface, and software for voltage protocols and current analysis.

• Prepare healthy defolliculated oocytes and inject the target cRNA or construct;
• Published TEVC and oocyte-expression protocols commonly record after expression incubation rather than immediately after injection, with reported expression windows depending on the expressed target.

• Prepare microelectrodes from glass capillaries and fill them with conductive internal solution;
• Conventional TEVC commonly uses KCl-filled electrodes, while published agarose-cushion electrodes used a 1% agarose cushion at the electrode tip and produced stable recordings for more than 1 h with reported input resistance of 1-4 MΩ.

• Prepare the recording bath and perfusion solutions according to the biological question;
• For ligand-gated channels, fast solution exchange is important because slow agonist application can distort activation kinetics.

• Place one oocyte in the recording chamber under bath solution, impale it with the voltage-sensing electrode and current-injecting electrode, and begin voltage clamp only after a stable resting potential and stable electrode signals are obtained.

• Hold the oocyte at a command potential and apply voltage steps, ramps, ligands, ions, inhibitors, or cofactors according to the target protein;
• In the SLAC1 example, TEVC was used to reconstitute multi-component ABA-dependent activation by co-expressing channel and signaling proteins, demonstrating that TEVC can measure regulated channel activity in oocytes.

• For ligand-gated receptors or pharmacology experiments, apply ligands or drugs through a perfusion system;
• Automated fast perfusion during two-microelectrode voltage clamp achieved a mean 10-90% current rise time of 55.0 ± 1.3 ms for acetylcholine-evoked muscle-type nicotinic acetylcholine receptor currents.

• For very fast or very large currents, interpret conventional TEVC cautiously because clamp quality worsens when membrane currents are large or rapid membrane charging is required;
• Lower-resistance electrodes, agarose-cushion electrodes, fast perfusion, or cut-open/vaseline-gap approaches may be needed for questions focused on fast kinetics.

• Acquire whole-oocyte current traces under defined command-voltage protocols and quantify current amplitude, current-voltage relationships, ligand concentration-response relationships, blocker inhibition, activation or deactivation kinetics, and reversal potential only when the voltage control and solution exchange are adequate for that measurement.

• Use uninjected or vehicle-injected oocytes as negative controls when measuring heterologously expressed currents, and use a known functional construct or previously validated target condition as a positive control when testing expression, ligand response, or pharmacological modulation.

• When comparing constructs, ligands, or conditions, analyze biological replicates as separate oocytes and report the number of oocytes and batches where available, because oocyte-expression studies can vary across individual cells and preparations.

The recorded current is very large or activates too rapidly for reliable voltage control.

Possible cause:
The large membrane area of Xenopus oocytes and electrode resistance can produce voltage errors and slow clamp performance.
Literature-supported solution:
Reduce current amplitude when experimentally possible, use lower-resistance electrodes, or use specialized approaches such as agarose-cushion electrodes or cut-open/vaseline-gap methods for fast kinetics.

Ligand-evoked current kinetics appear slowed or distorted.

Possible cause:
Solution exchange around a large oocyte can be too slow for fast ligand-gated channels.
Literature-supported solution:
Use fast perfusion or concentration-jump delivery; published TEVC fast perfusion achieved 55.0 ± 1.3 ms 10-90% rise time in acetylcholine-evoked current recordings.

Recording stability declines after impalement.

Possible cause:
Electrode leakage or unstable intracellular access can compromise long recordings.
Literature-supported solution:
Agarose-cushion electrodes were reported to reduce KCl leakage and maintain stable recordings for more than 1 h.